文献速递脑血管病外科神经重症

显微手术与术前栓塞联合显微手术治疗脑动静脉畸形的比较:系统综述与Meta分析

Microsurgery versus Microsurgery With Preoperative Embolization for Brain Arteriovenous Malformation Treatment: A Systematic Review and Meta-analysis.
PubMed 文献 · Neurosurgery · 2022-10-26

结果显示两组在畸形血管团闭塞率、死亡率、手术并发症、mRS恶化及术中出血量方面均无显著差异。

要点

  • 两组在bAVM闭塞率、死亡率、并发症、mRS恶化和术中出血量方面均无显著差异。
  • 对于单纯显微手术结果可接受的bAVM,作者认为可合理跳过不必要的术前栓塞,因术后并发症风险更高。

核心结论

  • Meta分析显示,MS组与E+MS组在bAVM闭塞率、死亡率、并发症、mRS恶化和术中出血量方面均无显著差异。
  • 对于单纯显微手术结果可接受的bAVM,鉴于术后并发症风险更高,作者认为可合理跳过不必要的术前栓塞。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、PubMed和Embase数据库。
  • 主要结局为bAVM闭塞,次要结局包括术中出血量(mL)、并发症、mRS恶化及死亡率。
  • 采用logit转换法计算结局的合并比例,分类数据用Mantel-Haenszel法估计OR,连续数据用逆方差法估计均数差。

主要发现

  • bAVM闭塞率:MS组94.1% vs E+MS组95.6%,OR=1.15(95%CI 0.63-2.11),P=.65,无显著差异。
  • 死亡率:MS组1.7% vs E+MS组2%,OR=0.88(95%CI 0.30-2.58),P=.82,无显著差异。
  • 手术并发症:MS组18.2% vs E+MS组27.2%,OR=0.47(95%CI 0.19-1.17),P=.10,无显著差异。
  • mRS恶化:MS组21.2% vs E+MS组18.5%,OR=1.08(95%CI 0.33-3.54),P=.9,无显著差异。
  • 术中出血量:均数差=182.89(95%CI -87.76至453.55),P=.19,无显著差异。

临床怎么用

  • 对于单纯显微手术结果可接受的bAVM,作者认为可合理跳过不必要的术前栓塞,因术后并发症风险更高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative embolization has traditionally been regarded as a safe and effective adjunct to microsurgical treatment of brain arteriovenous malformations (bAVM). However, there is currently no high-level evidence to ascertain this presumption. OBJECTIVE: To compare the outcomes of microsurgery (MS) vs microsurgery with preoperative embolization (E + MS) in patients with bAVM through systematic review. METHODS: We searched MEDLINE, PubMed, and Embase. The primary outcome was bAVM obliteration. Secondary outcomes were intraoperative bleeding (mL), complications, worsened modified Rankin Scale (mRS), and mortality. The pooled proportions of outcomes were calculated through the logit transformation method. The odds ratio (OR) of categorical data and mean difference of continuous data were estimated through the Mantel-Haenszel and the inverse variance methods, respectively. RESULTS: Thirty-two studies met the eligibility criteria. One thousand eight hundred twenty-eight patients were treated by microsurgery alone, and 1088 were treated by microsurgery with preoperative embolization, respectively. The meta-analysis revealed no significant difference in AVM obliteration (94.1% vs 95.6%, OR = 1.15 [0.63-2.11], P = .65), mortality (1.7% vs 2%, OR = 0.88 [0.30-2.58], P = .82), procedural complications (18.2% vs 27.2%, OR = 0.47 [0.19-1.17], P = .10), worsened mRS (21.2% vs 18.5%, OR = 1.08 [0.33-3.54], P = .9), and intraoperative blood loss (mean difference = 182.89 [-87.76, 453.55], P = .19). CONCLUSION: The meta-analysis showed no significant difference in AVM obliteration, mortality, complications, worse mRS, and intraoperative blood loss between MS and E + MS groups. For AVMs where MS alone has acceptable results, it is reasonable to bypass unnecessary preoperative embolization given higher postoperative complication risk.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Sattari SA, Shahbandi A, Yang W, et al. Microsurgery versus Microsurgery With Preoperative Embolization for Brain Arteriovenous Malformation Treatment: A Systematic Review and Meta-analysis. Neurosurgery. 2022. PMID: 36519858. doi:10.1227/neu.0000000000002171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。